Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122724982 | 12272498 | 2 | F | 20160309 | 20160915 | 20160415 | 20160921 | EXP | CA-JNJFOC-20160314404 | JANSSEN | 25.66 | YR | A | M | Y | 70.00000 | KG | 20160921 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122724982 | 12272498 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 0 | 400 | MG | LYOPHILIZED POWDER | ||||||
122724982 | 12272498 | 2 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | U | 103772 | 5 | MG/KG | LYOPHILIZED POWDER |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122724982 | 12272498 | 1 | Crohn's disease |
122724982 | 12272498 | 2 | Crohn's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122724982 | 12272498 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122724982 | 12272498 | Fistula | |
122724982 | 12272498 | Pyrexia | |
122724982 | 12272498 | Rhinorrhoea | |
122724982 | 12272498 | Vomiting | |
122724982 | 12272498 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |